GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 Jan 2014 06:20 PM
RNS
Director/PDMR Shareholding
16 Jan 2014 06:19 PM
RNS
Director/PDMR Shareholding
16 Jan 2014 12:14 PM
RNS
Director/PDMR Shareholding
15 Jan 2014 04:48 PM
RNS
Replacement Director/PDMR Shareholding
13 Jan 2014 04:50 PM
RNS
Director/PDMR Shareholding
13 Jan 2014 04:49 PM
RNS
Director/PDMR Shareholding
13 Jan 2014 02:08 PM
RNS
Director/PDMR Shareholding
13 Jan 2014 02:08 PM
RNS
Director/PDMR Shareholding
10 Jan 2014 05:34 PM
RNS
Director/PDMR Shareholding
10 Jan 2014 03:13 PM
RNS
Director/PDMR Shareholding
10 Jan 2014 03:11 PM
RNS
Director/PDMR Shareholding
09 Jan 2014 05:26 PM
RNS
Director/PDMR Shareholding
09 Jan 2014 07:00 AM
RNS
FDA approves MEK/BRAF combination therapy
06 Jan 2014 04:41 PM
RNS
Director/PDMR Shareholding
03 Jan 2014 09:43 AM
RNS
Director/PDMR Shareholding
03 Jan 2014 09:39 AM
RNS
Director/PDMR Shareholding
02 Jan 2014 03:59 PM
RNS
Total Voting Rights
23 Dec 2013 03:08 PM
RNS
Director/PDMR Shareholding
18 Dec 2013 05:02 PM
RNS
FDA approves ANORO ELLIPTA
17 Dec 2013 05:50 PM
RNS
Transaction in Own Shares
16 Dec 2013 05:50 PM
RNS
Transaction in Own Shares
16 Dec 2013 07:00 AM
RNS
GSK to increase stake in its Indian pharma. co.
13 Dec 2013 06:11 PM
RNS
Transaction in Own Shares
12 Dec 2013 05:53 PM
RNS
Transaction in Own Shares
11 Dec 2013 05:07 PM
RNS
Transaction in Own Shares
11 Dec 2013 04:58 PM
RNS
Director/PDMR Shareholding
11 Dec 2013 04:56 PM
RNS
Director/PDMR Shareholding
11 Dec 2013 03:31 PM
RNS
Board Committee change
10 Dec 2013 05:16 PM
RNS
Transaction in Own Shares
09 Dec 2013 05:28 PM
RNS
Transaction in Own Shares
09 Dec 2013 03:54 PM
RNS
Director/PDMR Shareholding
05 Dec 2013 05:53 PM
RNS
Transaction in Own Shares
04 Dec 2013 05:12 PM
RNS
Transaction in Own Shares
03 Dec 2013 05:31 PM
RNS
Transaction in Own Shares
02 Dec 2013 05:03 PM
RNS
Transaction in Own Shares
02 Dec 2013 12:17 PM
RNS
Total Voting Rights
29 Nov 2013 05:19 PM
RNS
Transaction in Own Shares
29 Nov 2013 12:40 PM
RNS
Director/PDMR Shareholding
28 Nov 2013 05:48 PM
RNS
Transaction in Own Shares
27 Nov 2013 05:24 PM
RNS
Transaction in Own Shares
25 Nov 2013 05:14 PM
RNS
Director/PDMR Shareholding
22 Nov 2013 01:43 PM
RNS
Tivicay? (dolutegravir) - positive CHMP opinion
20 Nov 2013 07:00 AM
RNS
GSK completes partial sale of Aspen
19 Nov 2013 03:21 PM
RNS
GSK intends to divest part holding in Aspen
18 Nov 2013 05:40 PM
RNS
Director/PDMR Shareholding
18 Nov 2013 01:16 PM
RNS
Relvar Ellipta receives EC marketing authorisation
15 Nov 2013 05:21 PM
RNS
Blocklisting Interim Review
15 Nov 2013 05:16 PM
RNS
Director/PDMR Shareholding
15 Nov 2013 05:10 PM
RNS
Transaction in Own Shares
14 Nov 2013 05:17 PM
RNS
Transaction in Own Shares

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings